Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
possible extension subject to funding). The group works at the interface of clinical and laboratory science, aiming to better understand and develop novel treatments for neurological disorders. In particular
-
used. AI methods for generating regulatory hypotheses between genes, hormones and physical properties will also be developed. Applicants must have/be close to obtaining a PhD or MPhil in Computational
-
, cultural practices and technologies between China and the Mediterranean or any sub-region between the two at any period up to the present day. This Research Fellowship is part of a broader programme, which
-
, cultural practices and technologies between China and the Mediterranean or any sub-region between the two at any period up to the present day. This Research Fellowship is part of a broader programme, which
-
are invited for the 2026 Research Fellowship awards. Up to four Research Fellowships will be awarded in this competition. Applicants should have submitted their PhD after 1 October 2024, or be on track
-
Practitioners with experience in clinical neurology at greater than ST3 level, who hold a PhD in clinical neuroscience/biological sciences. Experience in clinical trials is desirable. Click the 'Apply' button
-
of an integrated approach to risk-stratified screening, following the success of the BRAID trial. This work will help inform NHS Breast Screening Programme policy, assessing the value of supplemental imaging based
-
bioprocessing technologies to deliver efficient pathways for upcycling captured carbon into high value products. The successful candidate will have a PhD, or be studying towards a PhD, in synthetic biology or a
-
Sciences (HSPS) and also has a vibrant MPhil and PhD programme. There are currently about 80 students working on PhDs on a diverse range of topics in sociology. Further information about research interests
-
neuroscience, with the aim of improving mental health outcomes in both non-clinical and clinical populations. We are based at the MRC Cognition and Brain Sciences Unit, University of Cambridge, a world-leading